Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
IPO News

| More

CX Partners-backed Veeda Clinical Research files for IPO to raise 831 cr

Posted On: 2021-09-29 22:15:54 (Time Zone: IST)


Clinical research organisation Veeda Clinical Research Limited has filed its draft red herring prospectus (DRHP) with capital markets regulator Securities and Exchange Board of India (Sebi) on Tuesday, 28 September 2021 to raise funds from the primary markets.

The issue will consist of an issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders.

Investors participating in OFS include CX Alternative Investment Fund aggregating up to Rs 8.08 crore, Rs 90.19 crore by Arabelle Financial Services Limited, Rs 259.77 crore by Bondway Investment Inc., Rs 0.04 crore by Stevey International Corporation and Rs 141.93 crore by Basil Private Limited.

The company intends to utilise net proceeds from the fresh issue for repayment of the debt, funding capital expenditure, Investing/funding further acquisition of subsidiary Bioneedsfunding working capital requirements besides general corporate purposes.

The Ahmedabad-based company is backed by CX Partners, in June announced raising $16 million from PE firms Sabre Partners, and high networth individuals including Pranab Mody of JB Chemicals, Havells India family office, Nikhil Vora of Sixth Sense Ventures and Arjun Bhartia of Jubilant Group among others, according to a report by moneycontrol. Furthermore, to support its capabilities and to offer top-notch clinical service for novel drugs, Veeda acquired a 50.1% stake in Bangalore-based Bioneeds India Private Limited, after it acquired a substantial minority stake in the company during March and July 2021.

Veeda, grown from a single facility in 2004 to now having 4 facilties and the capability to process 1L samples per month, is one of the largest independent full service clinical research organization ("CRO") in India as of March 31, 2020, on the basis of revenue, according to the Frost & Sullivan report represented in its DRHP. It specializes in the focused segment of Bio Availability / Bio Equivalence (BA/BE) studies.In addition to BA/BE tests, it offers a broad range of services across most aspects of the drug development and drug launch value chain throughout the global markets including North America, Europe and Asia. In FY21 it has completed studies for 157 clients, some of the prominent names being Dr Reddy's, Mankind Pharma, Granules India, Novugen Pharma.

Veeda has a full suite of clinical trials including pre-clinical, early phase and late phase clinical trials, together with related services. In particular, it states, we have expertise in pharmacokinetics (PK) studies as well as trials in generic molecules, New Chemical Entities (NCEs), large molecules and biosimilars.

As of March 2021, Veeda has conducted more than 3,500 trials and developed more than 1,000 bio-analytical methods spread across generics. It has also been able to complete over 85 global inspections with regulatory authorities like USFDA, UK-MHRA, WHO, ANVISA, DGCI and EMA.

Veeda Clinical's revenue from operations stood at Rs 195.81 crore during the year ended March 2021, while its profit after tax during the year stood at Rs 62.97 crore.

Globally the market for biosimilars is estimated to grow at a 17.3% CAGR. India is expected to see a growth due to the large patient cliff expected in the next 5 years, more so because the reduced cost of development biosimilars in the country, less stringent approval criteria, lower labour besides other factors global generic players have begun outsourcing BA/BE trials to the country.

The CRO Market in India captures 3% of the global market share by value and is expected to be the fastest growing market with a CAGR of 12% between 2021-2026.

SBI Capital Markets Limited, ICICI Securities Limited, JM Financial Limited and Systematix Corporate Services Limited are the book running lead managers to the issue.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

10 Things to know about RateGain Travel Technologies Limited

Anand Rathi Wealth IPO subscribed 9.78 times on Day 3, NII portion booked 25.42 times

Cloud Services firm ESDS Software Solution Limited gets Sebi nod to float IPO

MapmyIndia's IPO to open on December 09, 2021

Anand Rathi Wealth IPO subscribed 3.02 times on Day 2, retail portion booked 4.77 times

Tega Industries IPO attracts highest QIB subscription in the last decade, Issue subscribed 219 times

Star Health IPO fails to attract investor Interest, Anand Rathi and Tega Industries make merry

Anand Rathi Wealth raises Rs. 193.87 crore from 12 anchor investors

Mining Player Tega Industries raises Rs 186 crore from 14 anchor investors

Anand Rathi Wealth Limited's initial public offering to open on December 2, 2021

10 things to know about Star Health and Allied Insurance Company Limited

Angel Broking recommends 'Subscribe' to Star Health and Allied Insurance IPO

Mumbai-based Jesons Industries files DRHP with Sebi for IPO

Delhi based Electronics Contract Manufacturer Elin Electronics files for Rs 760 crore IPO

Tracxn Technologies and Puranik Builders gets Sebi's nod to float IPO

Kolkata-based Tega Industries Limited's IPO to open on December 01, 2021

Star Health and Allied Insurance Company Ltd IPO to open on Nov 30, 2021

10 things to watch out for in Paytm's RHP as the company heads closer to its mega IPO

ESAF Small Finance Bank gets Sebi nod for Rs 998 cr IPO

Anand Rathi Wealth gets Sebi nod for IPO

Penna Cement gets Sebi nod for Rs 1,550 crore IPO

Kolkata based GPT Healthcare files IPO papers with Sebi

Everstone backed SJS Enterprises gets SEBI green signal for its IPO

Ascent Capital-backed Radiant Cash Management Services files draft papers with SEBI to raise funds via IPO

Fino Payments Bank, the first profitable fintech gets Sebi nod for its IPO

Omni Channel Retail Pharmacy Chain, Wellness Forever files for an IPO

Diversified Co., PKH Ventures files its IPO Papers

Waaree Energies files DRHP for its IPO

IPO of Shri Venkatesh Refineries Limited to open on BSE SME platform on Sept 29

Paras Defence raises Rs. 51 crores from Anchor Investors

Defence and Space Tech Co, Paras becomes most oversubscribed IPO in Capital Markets History

Hyderabad based Consumer Durable Retail Chain, Electronics Mart India files for Rs 500 cr IPO

Hyderabad based Hariom Pipe files for Rs 120 crore IPO

Florintree backed Defence Electronics Co. Data Patterns files for IPO

Paras Defence and Space Technologies Limited's IPO to open on September 21, 2021

Kolkata based Metal and Mining Co., Tega Industries files for its IPO

Prudent Corporate Advisory Services Limited files DRHP with SEBI

Private Market Intelligence SaaS Platform, Tracxn files for an IPO

Inspira Enterprise India Limited files DRHP with SEBI

Aptus Value Housing Finance India Limited, Issue subscribed 0.37 times, Retail portion booked 0.54 times on day 2

Nuvoco's IPO final day: Issue subscribed 1.71 times on final day, Best interest from QIB subscribed 4.23 times

Keventer Agro Limited files DRHP with SEBI

Aptus Value Housing Finance India Limited raises Rs. 834 crs from 21 Anchor Investors

Retail Segment laps up 80 % of CarTrade's IPO on Day 1

Nuvoco sees Steady Retail Category Interest 31% Subscribed on Day 1

Hyderabad based Edible Oil Co., Gemini Edibles & Fats files for Rs. 2500 cr IPO

Nuvoco Vistas raises Rs. 1,500 crores from Anchor Investors, 30% of the IPO size of Rs. 5,000 crores

Exxaro Tiles Limited IPO final day: Issue subscribed 22.57 times, Best interest from Retail investors subscribed 39.88 times

Devyani International Limited IPO Final Day: Issue subscribed 116.71 times, Retail portion booked 39.51

Devyani International Limited Issue subscribed 6.61 times, Retail portion booked 22.94 on day 2


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020